A Kaplan-Meier analysis indicated that the NSCLC patients whose tumors showed high levels of periostin expression (periostin-H) had significantly shorter overall survival times compared with those with low levels of periostin expression (periostin-L; P=0.036, log-rank test; Fig. 4). This evidence concerns the gene POSTN and non-small cell lung carcinoma.